相关实验视频
Updated: Sep 12, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.3K
在炎症性肠病遗传学和微生物群的地理多样性
Fangjia Hao1, Wenyi Zhu2, Jiaying Zheng1
1Microbiota I-Center (MagIC), Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
Trends in microbiology
|August 5, 2025
概括
地理多样性显著影响炎症性肠病 (IBD) 风险和进展,由于遗传学,环境和肠道微生物的变化. 为了更好的诊断和治疗,研究必须包括多样化的群体.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 人口健康 人口健康
背景情况:
- 炎症性肠病 (IBD) 是由于对肠道微生物群的反应而导致遗传敏感个体的免疫失调引起的.
- 环境因素和微生物组成显著影响IBD的发展和进展.
- 主体遗传学,环境和微生物群的地理差异至关重要,但在IBD研究中经常被忽视.
研究的目的:
- 审查IBD决定因素的地理差异.
- 探索不同种群中遗传学,环境和微生物群之间的相互作用.
- 强调IBD研究和临床试验中需要多样性.
主要方法:
- 在地理上多样化的队列中对IBD决定因素的文献综述.
- 对驱动IBD出现和进展的相互关系的分析.
- 综合当前对IBD的地理和人口多样性的理解.
主要成果:
- 在不同地理区域,IBD遗传倾向,环境暴露和肠道微生物特征存在显著差异.
- 这些变化深刻影响IBD风险,疾病进展和对治疗的反应.
- 忽视地理多样性限制了当前IBD研究结果的概括性.
结论:
- 拥抱地理和人口多样性对于推进IBD诊断和治疗方法至关重要.
- 未来的IBD研究和临床试验必须积极包括各种人群,以确保研究结果广泛适用.
- 了解特定人群的IBD驱动因素可以导致更个性化和更有效的治疗策略.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
324
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
Inflammatory Bowel Disease II: Crohn's Disease
383
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Irritable Bowel Syndrome I: Introduction
388
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
388
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Inflammatory Bowel Disease IV: Pharmacological Management
190
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
190

